​

Onconetix Ownership | Who Owns Onconetix?

OverviewRevenueFinancialsChart

Onconetix Ownership Summary

Onconetix is owned by 2.66% institutional investors, 0.61% insiders, and 96.73% retail investors.

ONCO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOnconetix2.66%0.61%96.73%
SectorHealthcare Stocks 35.38%11.35%53.27%
IndustryBiotech Stocks 33.91%11.39%54.70%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20265-16,725-2-5---

Recent Insider Transactions

DateNameRoleActivityValue
Apr 21, 2026HRT FINANCIAL LP-Sell$34.30K
Apr 17, 2026HRT FINANCIAL LP-Buy$25.28K
Apr 16, 2026HRT FINANCIAL LP-Sell$39.32K
Apr 20, 2026HRT FINANCIAL LP-Sell$70.85K
Apr 15, 2026HRT FINANCIAL LP-Buy$70.34K

Insider Transactions Trends

DateBuySell
2026 Q233
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--

ONCO Ownership FAQ

Who Owns Onconetix?

Onconetix shareholders are primarily institutional investors at 2.66%, followed by 0.61% insiders and 96.73% retail investors. The average institutional ownership in Onconetix's industry, Biotech Stocks , is 33.91%, which Onconetix falls below.

Does Blackrock own Onconetix?

BlackRock is not among the top 10 institutional shareholders of Onconetix.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools